ArticleCureus2026
Microbiological Profile of Pathogens Among Patients at a Tertiary Care Hospital in Mumbai, India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobial resistance (AMR) has emerged as one of the most significant threats to global public health, compromising the effective management of infectious diseases. Institutional antibiograms provide valuable information on local pathogen distribution and antimicrobial susceptibility patterns, thereby supporting evidence-based empirical therapy and antimicrobial stewardship. This study aimed to determine the microbiological profile of pathogens and their antimicrobial susceptibility patterns among patients attending a hospital in India.
methodsA retrospective observational study was conducted in the Department of Microbiology, Bhatia Hospital, Mumbai, Maharashtra, India. Laboratory records of culture-positive clinical specimens received between January and December 2025 were reviewed. A total of 2,075 non-duplicate, clinically significant isolates obtained from various clinical specimens were included. Bacterial and fungal isolates were identified using standard microbiological methods and the VITEK® 2 Compact system (bioMérieux, Marcy-l'Étoile, France). Antimicrobial susceptibility testing was performed using the VITEK® 2 Compact system and interpreted according to the Clinical and Laboratory Standards Institute (CLSI M100, 35th edition 2025) guidelines. Organism distribution, specimen-wise and area-wise frequency, antimicrobial susceptibility profiles, and multidrug-resistant organism (MDRO) prevalence were analysed.
resultsA total of 2,075 clinically significant isolates were recovered during the study period. Gram-negative bacteria predominated, accounting for 1,627 (78.4%) isolates, followed by Gram-positive bacteria (299; 14.4%) and fungal isolates (149; 7.2%). The most frequently isolated pathogens were
conclusionGram-negative bacteria were the predominant pathogens isolated with a substantial burden of MDROs. The observed antimicrobial resistance patterns emphasize the need for continuous microbiological surveillance, regular updating of institutional antibiograms, and implementation of robust antimicrobial stewardship programs to optimize empirical antimicrobial therapy and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.